DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ortho (Ethinyl Estradiol) - Summary



ORTHO EVRA® is a combination transdermal contraceptive patch with a contact surface area of 20 cm2. It contains 6.00 mg norelgestromin and 0.75 mg ethinyl estradiol (EE), and releases 150 micrograms of norelgestromin and 20 micrograms of EE to the bloodstream per 24 hours.

ORTHO EVRA® is indicated for the prevention of pregnancy.
See all Ortho indications & dosage >>


Media Articles Related to Ortho (Ethinyl Estradiol)

Orthostatic Hypotension
Source: MedicineNet Addison Disease Specialty [2015.05.14]
Title: Orthostatic Hypotension
Category: Diseases and Conditions
Created: 6/11/2009 12:00:00 AM
Last Editorial Review: 5/14/2015 12:00:00 AM

Orthopedist Offers Tips for Preventing Shoulder Injuries
Source: MedicineNet Frozen Shoulder Specialty [2015.04.24]
Title: Orthopedist Offers Tips for Preventing Shoulder Injuries
Category: Health News
Created: 4/23/2015 12:00:00 AM
Last Editorial Review: 4/24/2015 12:00:00 AM

Doctors Aren't Doing Enough to Get Patients to Exercise
Source: Medscape Internal Medicine Headlines [2015.10.01]
Orthopedists get paid for fixing problems, not preventing them, a noted sports medicine doctor observes. But motivating patients to take control of their fitness is the most important part of the job.
Medscape Orthopedics

Dizziness after getting up may indicate a serious health problem, study finds
Source: Headache / Migraine News From Medical News Today [2015.09.24]
New research from the Harvard Medical School suggests that dizziness on getting up could be a sign of a serious underlying medical problem known as orthostatic hypotension.

Some radiation okay for expectant mother and fetus
Source: Radiology / Nuclear Medicine News From Medical News Today [2015.08.07]
Study finds doses are well below thresholds considered riskyAccording to a new study in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), imaging studies necessary to diagnose...

more news >>

Published Studies Related to Ortho (Ethinyl Estradiol)

[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study]. [Article in Chinese] [2014]
with placebo in reducing symptoms of premenstrual dysphoric disorder (PMDD)... CONCLUSIONS: YAZ could improve symptoms of PMDD better than placebo, while

An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. [2012]
and premenstrual syndrome (PMS)... CONCLUSIONS: These data, although not consistent, indicate that continuous LNG/EE

Bond strength of orthodontic light-cured resin-modified glass ionomer cement. [2011.04]
The purpose of this study was to compare the bond strengths and debonded interfaces achieved with light-cured resin-modified glass ionomer cement (RMGIC) and conventional light-cured composite resin. In addition, the effects of acid etching and water contamination were examined... Enamel surfaces, with or without water contamination and with or without acid etching, had the same or a greater bond strength than Transbond.

In-vitro evaluation of various treatments to prevent demineralization next to orthodontic brackets. [2010.12]
INTRODUCTION: One common negative side effect of orthodontic treatment with fixed appliances is the development of incipient caries lesions around brackets, particularly in patients with poor oral hygiene. Bio-available minerals from cement containing amorphous calcium phosphate (ACP) might facilitate remineralization and inhibit lesion development. Our objective was to compare the potential of ACP-containing resin cement, fluoride varnish, resin sealer, and MI Paste (GC America, Alsip, Ill) under similar in-vitro conditions to prevent incipient caries lesions next to brackets on teeth... CONCLUSIONS: Both light-cured filled resin (Pro-seal) and fluoride varnish (Vanish) might prevent enamel demineralization next to orthodontic brackets exposed to cariogenic conditions, but the observed positive effects of Aegis-Ortho and MI Paste were not significant. Copyright (c) 2010 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.

Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects. [2010.12]
BACKGROUND: Limited orthodontics are shown to be effective in the correction of infrabony defects. Studies have also demonstrated the efficacy of using enamel matrix derivative (EMD) with demineralized freeze-dried bone allograft (DFDBA) to treat infrabony defects. This study aims to compare the clinical efficacy of limited orthodontics combined with EMD/DFDBA in the treatment of 2- or 3-wall infrabony defects... CONCLUSION: Although both treatment modalities were effective in managing 2- or 3-wall infrabony defects, limited orthodontics provided an additional benefit to EMD/DFDBA in 2-wall defects.

more studies >>

Clinical Trials Related to Ortho (Ethinyl Estradiol)

The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA� in Healthy Women [Completed]
The purpose of this study is to assess the bioequivalence of the contraceptive hormones of ORTHO EVRA when the patch is applied with and without an adhesive overlay.

Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks [Active, not recruiting]
The purpose of the study is to assess the occurrence of venous thromboembolism (blood clots), stroke, and heart attack in current users of ORTHO EVRA compared to current users of norgestimate-containing oral contraceptives with 35 mcg ethinyl estradiol with special attention to duration of use. The study uses data from the PharMetrics Patient-Centric Database, which is a medical claims database.

Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen� in Healthy Female Subjects [Completed]

Discontinuation of Lens Wear in New Ortho-k Children (DOEE2) [Active, not recruiting]

Continuous Use of the Contraceptive Patch and the Personal Economic Impact. [Withdrawn]
Dr. Eleanor Drey in the Department of Obstetrics, Gynecology and Reproductive Sciences UCSF is conducting a study to examine the personal and economic impact of continuous use of ORTHO EVRA, the contraceptive patch, on menstrual related symptoms for women who report having severe menstrual related symptoms.

more trials >>

Page last updated: 2015-10-01

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015